PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3494043-5 1987 Bromocriptine plus low-dose cyclosporine led to more marked decreases in the incidence of EAU and anti-S-antigen antibody titers as well as in the lymphocyte proliferative assay (P less than 0.01 for males, P less than 0.0005 for females). Cyclosporine 28-40 S-antigen visual arrestin Rattus norvegicus 103-112 2625778-2 1989 When administered daily on days 0-14 after immunization with S-antigen, CsA was the most effective of all in inhibiting EAU followed by CsG: 20-30 mg/kg/day of CsG appeared to have the same effect as 5 mg/kg/day of CsA. Cyclosporine 72-75 S-antigen visual arrestin Rattus norvegicus 61-70 2962794-1 1988 Cyclosporine (CsA) was previously reported to effectively suppress the induction of experimental autoimmune uveoretinitis (EAU) in rats immunized with S-antigen. Cyclosporine 0-12 S-antigen visual arrestin Rattus norvegicus 151-160 2962794-1 1988 Cyclosporine (CsA) was previously reported to effectively suppress the induction of experimental autoimmune uveoretinitis (EAU) in rats immunized with S-antigen. Cyclosporine 14-17 S-antigen visual arrestin Rattus norvegicus 151-160 3901986-1 1985 The use of locally applied cyclosporine was investigated in the retinal S-antigen-induced experimental autoimmune uveitis (EAU) model in Lewis rats. Cyclosporine 27-39 S-antigen visual arrestin Rattus norvegicus 64-81 3503117-3 1986 Daily subcutaneous injections of Cyclosporine (CsA) (20 mg/kg) from the day of immunization totally prevented the ocular disease, clinically and histologically, confirming earlier experiments in S-antigen induced experimental autoimmune uveoretinitis in rats. Cyclosporine 33-45 S-antigen visual arrestin Rattus norvegicus 195-204 3503117-3 1986 Daily subcutaneous injections of Cyclosporine (CsA) (20 mg/kg) from the day of immunization totally prevented the ocular disease, clinically and histologically, confirming earlier experiments in S-antigen induced experimental autoimmune uveoretinitis in rats. Cyclosporine 47-50 S-antigen visual arrestin Rattus norvegicus 195-204 3489788-1 1986 Cyclosporine A (CsA), one compound in the family of cyclosporines, has effectively modulated the course of S-antigen induced experimental autoimmune uveitis (EAU). Cyclosporine 0-14 S-antigen visual arrestin Rattus norvegicus 107-116 3489788-1 1986 Cyclosporine A (CsA), one compound in the family of cyclosporines, has effectively modulated the course of S-antigen induced experimental autoimmune uveitis (EAU). Cyclosporine 16-19 S-antigen visual arrestin Rattus norvegicus 107-116 3871750-6 1985 Cyclosporine was also unique in its effect on the immune responses of the rats by selectively inhibiting only the specific T-cell-mediated responses to S-antigen (delayed skin response and lymphocyte response in culture), while having no negative effect on antibody production or the lymphocyte response to the polyclonal mitogen, concanavalin A. Cyclosporine 0-12 S-antigen visual arrestin Rattus norvegicus 152-161 6234255-1 1984 Cyclosporine (CsA) has been shown to be effective in preventing S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) in Lewis rats. Cyclosporine 0-12 S-antigen visual arrestin Rattus norvegicus 64-73 6234255-1 1984 Cyclosporine (CsA) has been shown to be effective in preventing S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) in Lewis rats. Cyclosporine 0-12 S-antigen visual arrestin Rattus norvegicus 75-79 6234255-1 1984 Cyclosporine (CsA) has been shown to be effective in preventing S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) in Lewis rats. Cyclosporine 14-17 S-antigen visual arrestin Rattus norvegicus 64-73 6234255-1 1984 Cyclosporine (CsA) has been shown to be effective in preventing S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) in Lewis rats. Cyclosporine 14-17 S-antigen visual arrestin Rattus norvegicus 75-79 6234255-2 1984 Alterations in the humoral immune responses associated with CsA therapy are illustrated by lower peak and delayed production of circulating anti-S-Ag antibodies in a proportional relationship to the dose of CsA in EAU. Cyclosporine 60-63 S-antigen visual arrestin Rattus norvegicus 145-149 6234255-2 1984 Alterations in the humoral immune responses associated with CsA therapy are illustrated by lower peak and delayed production of circulating anti-S-Ag antibodies in a proportional relationship to the dose of CsA in EAU. Cyclosporine 207-210 S-antigen visual arrestin Rattus norvegicus 145-149 3871429-1 1985 The effective inhibition of S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) by Cyclosporine (CsA) suggests strongly the important role of T-cells in the modulation of this disease. Cyclosporine 94-106 S-antigen visual arrestin Rattus norvegicus 28-37 3871429-1 1985 The effective inhibition of S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) by Cyclosporine (CsA) suggests strongly the important role of T-cells in the modulation of this disease. Cyclosporine 94-106 S-antigen visual arrestin Rattus norvegicus 39-43 3871429-1 1985 The effective inhibition of S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) by Cyclosporine (CsA) suggests strongly the important role of T-cells in the modulation of this disease. Cyclosporine 108-111 S-antigen visual arrestin Rattus norvegicus 28-37 3871429-1 1985 The effective inhibition of S-antigen (S-Ag) induced experimental autoimmune uveitis (EAU) by Cyclosporine (CsA) suggests strongly the important role of T-cells in the modulation of this disease. Cyclosporine 108-111 S-antigen visual arrestin Rattus norvegicus 39-43 3871429-5 1985 Lymphocyte preparations from lymph nodes draining the site of S-Ag immunization from CsA-treated animals demonstrated a different T-cell subset profile than did controls. Cyclosporine 85-88 S-antigen visual arrestin Rattus norvegicus 62-66 3871429-8 1985 These data suggest that CsA appears to prevent the development of inducer cells in the lymph nodes draining the S-Ag immunization site, the T-cell subgroup the authors have seen capable of inducing EAU. Cyclosporine 24-27 S-antigen visual arrestin Rattus norvegicus 112-116 7925680-8 1994 As for the immune responses to S-antigen in drug-treated rats, bucillamine suppressed the lymphocyte proliferation to S-antigen, which was further suppressed by combination therapy with CYA. Cyclosporine 186-189 S-antigen visual arrestin Rattus norvegicus 118-127 6600715-0 1983 Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis. Cyclosporine 0-13 S-antigen visual arrestin Rattus norvegicus 62-71 6600715-1 1983 We have previously shown that Cyclosporin A (CsA) is effective in preventing S-antigen (S-Ag)-induced experimental autoimmune uveitis (EAU). Cyclosporine 30-43 S-antigen visual arrestin Rattus norvegicus 77-86 6600715-1 1983 We have previously shown that Cyclosporin A (CsA) is effective in preventing S-antigen (S-Ag)-induced experimental autoimmune uveitis (EAU). Cyclosporine 30-43 S-antigen visual arrestin Rattus norvegicus 88-92 6600715-1 1983 We have previously shown that Cyclosporin A (CsA) is effective in preventing S-antigen (S-Ag)-induced experimental autoimmune uveitis (EAU). Cyclosporine 45-48 S-antigen visual arrestin Rattus norvegicus 77-86 6600715-1 1983 We have previously shown that Cyclosporin A (CsA) is effective in preventing S-antigen (S-Ag)-induced experimental autoimmune uveitis (EAU). Cyclosporine 45-48 S-antigen visual arrestin Rattus norvegicus 88-92 6600715-3 1983 Lymph nodes draining the site of S-Ag immunization were significantly smaller in the CsA-treated animals when compared to the nonprotected group (p less than 0.01), and also showed profound histologic alterations when compared to controls. Cyclosporine 85-88 S-antigen visual arrestin Rattus norvegicus 33-37 7204576-2 1981 Cyclosporin A (CS-A), a selective inhibitor of T lymphocytes, is reported here to prevent S antigen (S-Ag) induced uveitis in Lewis rats. Cyclosporine 0-13 S-antigen visual arrestin Rattus norvegicus 90-99 7204576-2 1981 Cyclosporin A (CS-A), a selective inhibitor of T lymphocytes, is reported here to prevent S antigen (S-Ag) induced uveitis in Lewis rats. Cyclosporine 0-13 S-antigen visual arrestin Rattus norvegicus 101-105